| Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe | Alzheimer's & dementia |  | | 2022 | 361 | 517 |
|
| Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework | European journal of nuclear medicine and molecular imaging | | | 2021 | 288 | 339 |
|
| Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison | European Journal of Nuclear Medicine and Molecular Imaging | | | 2021 | 348 | 250 |
|
| The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers | European journal of nuclear medicine and molecular imaging | | | 2021 | 226 | 329 |
|
| Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services — part 2 of 6 | Alzheimer's research & therapy | | | 2021 | 171 | 404 |
|
| 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework | European journal of nuclear medicine and molecular imaging | | | 2021 | 247 | 323 |
|
| Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services — part 6 of 6 | Alzheimer's research & therapy | | | 2021 | 133 | 169 |
|
| Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework | European journal of nuclear medicine and molecular imaging | | | 2021 | 269 | 578 |
|
| The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update | European Journal of Nuclear Medicine and Molecular Imaging | | | 2021 | 361 | 327 |
|
| Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework | European journal of nuclear medicine and molecular imaging | | | 2021 | 204 | 124 |
|
| Randomized controlled trial on the efficacy of a multilevel non-pharmacologic intervention in older adults with subjective memory decline: design and baseline findings of the E.Mu.N.I. study | Aging Clinical and Experimental Research |  | | 2020 | 460 | 1 |
|
| Basal forebrain metabolism in Alzheimer's disease continuum: relationship with education | Neurobiology of Aging | | | 2020 | 449 | 0 |
|
| Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease | European Journal of Nuclear Medicine and Molecular Imaging | | | 2020 | 417 | 6 |
|
| Short-term Sahaja Yoga meditation training modulates brain structure and spontaneous activity in the executive control network | Brain and Behavior | | | 2019 | 401 | 315 |
|
| Qualitative Scoring of the Pentagon Test: A Tool for the Identification of Subtle Cognitive Deficits in Isolated REM Sleep Behavior Disorder Patients | Archives of Clinical Neuropsychology | | | 2019 | 403 | 0 |
|
| The A/T/N model applied through imaging biomarkers in a memory clinic | European Journal of Nuclear Medicine and Molecular Imaging | | | 2019 | 430 | 6 |
|
| The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy | NeuroImage: Clinical | | | 2019 | 271 | 181 |
|
| Improving innovative decision-making: Training-induced changes in fronto-parietal networks | Brain and Cognition | | | 2018 | 323 | 0 |
|
